LSE

Allied Electronics & Automation Offers Phoenix Contact's New XTV Terminal Blocks With Push-X Direct Connection Technology

Retrieved on: 
Wednesday, January 11, 2023

FORT WORTH, Texas, Jan. 11, 2023 /PRNewswire/ -- Allied Electronics & Automation, a trading brand of RS Group plc (LSE: RS1), a global omni-channel provider of product and service solutions, is proud to offer Phoenix Contact's new XTV terminal blocks with Push-X connection technology. The new XTV terminal blocks are the first products on the market to incorporate Phoenix Contact's breakthrough Push-X direct connection technology, which enables easy, flexible, and virtually tool-free wiring and rewiring with minimal force, reduces installation times for all conductor types and cross sections, and paves the way for automated wiring.

Key Points: 
  • FORT WORTH, Texas, Jan. 11, 2023 /PRNewswire/ -- Allied Electronics & Automation , a trading brand of RS Group plc (LSE: RS1), a global omni-channel provider of product and service solutions, is proud to offer Phoenix Contact's new XTV terminal blocks with Push-X connection technology.
  • Phoenix Contact's Push-X direct connection technology paves the way for automated wiring in industrial applications.
  • For more information about Phoenix Contact's new Push-X connection technology and XTV terminal blocks, please visit the product page .
  • To compare and purchase Phoenix Contact's XTV terminal blocks with Push-X connection technology at AlliedElec.com, please click here .

LSE launches £50m accelerator for "social unicorns"

Retrieved on: 
Tuesday, January 10, 2023

Based at the London School of Economics and Political Science (LSE) , 100x aims to nurture high-potential social enterprises, enabling them to achieve positive impact on the scale of billions.

Key Points: 
  • Based at the London School of Economics and Political Science (LSE) , 100x aims to nurture high-potential social enterprises, enabling them to achieve positive impact on the scale of billions.
  • It emulates the successful business accelerator model from the private sector and aims to show how impact-driven organisations can break the cycle of grant-seeking and weak governance.
  • 100x Impact Accelerator will support two cohorts of ten social enterprises every year, with 70% of these coming from emerging markets.
  • Leslie Labruto, Director of 100x Impact Accelerator, said: "It's time to level the playing field for social enterprises.

LSE launches £50m accelerator for "social unicorns"

Retrieved on: 
Tuesday, January 10, 2023

Based at the London School of Economics and Political Science (LSE) , 100x aims to nurture high-potential social enterprises, enabling them to achieve positive impact on the scale of billions.

Key Points: 
  • Based at the London School of Economics and Political Science (LSE) , 100x aims to nurture high-potential social enterprises, enabling them to achieve positive impact on the scale of billions.
  • It emulates the successful business accelerator model from the private sector and aims to show how impact-driven organisations can break the cycle of grant-seeking and weak governance.
  • 100x Impact Accelerator will support two cohorts of ten social enterprises every year, with 70% of these coming from emerging markets.
  • Leslie Labruto, Director of 100x Impact Accelerator, said: "It's time to level the playing field for social enterprises.

Material Opportunities in Electrification Webinar: Stonegate Research Note

Retrieved on: 
Tuesday, December 20, 2022

Dallas, Texas--(Newsfile Corp. - December 20, 2022) - On December 14th, 2022, Stonegate Capital Partners held its Material Opportunities in Electrification Webinar.

Key Points: 
  • Dallas, Texas--(Newsfile Corp. - December 20, 2022) - On December 14th, 2022, Stonegate Capital Partners held its Material Opportunities in Electrification Webinar.
  • Each of these speakers focused on a key material used in the electrification of vehicles and the grid.
  • The speakers interact with their materials at different points in the supply chain and in a variety of geographic region.
  • It is this cross section of materials, processes, and locations that make each panelist a thought leader in their respective areas.

MD Medical Group Investments Plc: MD Medical Group opens new Medical centre in Moscow Region

Retrieved on: 
Sunday, January 22, 2023

MD Medical Group Investments Plc: MD Medical Group opens new Medical centre in Moscow Region

Key Points: 
  • MD Medical Group Investments Plc: MD Medical Group opens new Medical centre in Moscow Region
    Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group.
  • 13 January 2023 – MD Medical Group Investments Plc (“MD Medical Group”, “MDMG”, “Group” or the “Company”; LSE and MOEX: MDMG), a leading Russian private healthcare provider, today announces the opening of a new out-patient medical centre “Mother&Child Mytishchi” in Moscow Region.
  • The out-patient medical centre "Mother&Child Mytishchi" with a focus on preparation for pregnancy and childbirth is already the third such kind of centre for the Group in Moscow and Moscow Region.
  • The new clinic "Mother&Child Mytishchi" was created in line with MD Medical Group’s customary high standards of medical care and is fitted with world-class equipment.

Sale of IP addresses

Retrieved on: 
Sunday, January 22, 2023

The Company retains the rights over a further c.294,000 IPv4 addresses which will support growth in RM’s connectivity business.

Key Points: 
  • The Company retains the rights over a further c.294,000 IPv4 addresses which will support growth in RM’s connectivity business.
  • The IP addresses are classified as intangible assets and were acquired at nil value.
  • The Sale will therefore not affect the Company’s total net assets, other than the addition of the cash proceeds from the Sale which will be used to strengthen the balance sheet.
  • Approximately £4.1m of IP addresses were sold during FY22 (ending on 30 November 2022) which, due to the changing nature of these sales in the period, have been classified as other income for FY22 in line with the treatment of the sale of Intangible Assets.

Lenta IPJSC: Lenta Announces the Holding of the Board of Directors Meeting

Retrieved on: 
Sunday, January 22, 2023

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • St. Petersburg, Russia, 22 December 2022: Lenta IPJSC (LSE: LNTA, MOEX: LENT), one of the largest multi-format retail chains in Russia, today announces the holding of the Board of Directors meeting on 21 December 2022.
  • The agenda of the meeting:
    Reports of the Chairpersons of the Company’s Board Committees:
    a.
  • Report of the Chairwoman of the RemunerationCommittee;
    c. Report of the Chairwoman of the Nominations Committee.

AMUNDI ETF – Important Information – Mergers on Amundi Funds – 27/1/2023

Retrieved on: 
Sunday, January 22, 2023

Please be informed that Amundi will proceed to mergers operations on January 27th, 2023.

Key Points: 
  • Please be informed that Amundi will proceed to mergers operations on January 27th, 2023.
  • Only the Receiving ETF (LU1681044993) is listed on the London Stock Exchange.
  • The two LSE listings of the Receiving ETF will not be impacted by the operation.
  • The Name and the Benchmark Index of the Receiving ETF will remain same.

Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma

Retrieved on: 
Sunday, January 22, 2023

London, UK, 5 January 2023 – Arix Bioscience plc (“Arix” or the “Company”) (LSE: ARIX), a global venture capital company focused on investing in breakthrough biotechnology companies, today announces the agreement to acquire core portfolio company Twelve Bio in an all-share transaction in connection with an $85 million financing of Ensoma.

Key Points: 
  • London, UK, 5 January 2023 – Arix Bioscience plc (“Arix” or the “Company”) (LSE: ARIX), a global venture capital company focused on investing in breakthrough biotechnology companies, today announces the agreement to acquire core portfolio company Twelve Bio in an all-share transaction in connection with an $85 million financing of Ensoma.
  • Arix co-led the Ensoma financing as a new investor, investing $9 million.
  • Twelve Bio is a gene editing company pioneering the therapeutic application of next-generation CRISPR-Cas medicines.
  • Ensoma is a Boston-based genomic medicines company developing one-time in vivo treatments that precisely engineer any cell of the hematopoietic system.

MD Medical Group Investments Plc: MD Medical Group announcement of the Extraordinary General Meeting

Retrieved on: 
Sunday, January 22, 2023

MD Medical Group Investments Plc: MD Medical Group announcement of the Extraordinary General Meeting

Key Points: 
  • MD Medical Group Investments Plc: MD Medical Group announcement of the Extraordinary General Meeting
    Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • 30 December 2022 – MD Medical Group Investments Plc (“MD Medical Group”, “MDMG”, “Group” or the “Company”; LSE and MOEX: MDMG), a leading Russian private healthcare provider, announces that at a meeting on December 30, 2022 the Board of Directors of MD Medical Group Investments Plc called an Extraordinary General Meeting of shareholders to be held on 23 January 2023 at Lapino hospital, Lapino 111, Odintsovskiy district, Moscow Region, Russian Federation at 10.00 am Moscow time, to consider and, if thought fit, pass 1 resolution which will be proposed as special:
    To appoint GAC Auditors Ltd as the auditor of the separate financial statements of the Company for the year ended 31 December 2022 until the next annual general meeting of the Company and to authorize the Board of Directors to determine the remuneration of auditors.
  • The record date to participate the Extraordinary General Meeting of shareholders shall be 30 December 2022.